SK Pharmteco

Executive Summary

SK Pharmteco is a global Contract Development and Manufacturing Organization (CDMO) headquartered in Lyon, France, founded in 2019. It offers comprehensive drug development and manufacturing services for small molecules, biologics, and cell and gene therapies, operating a network of cGMP facilities worldwide. As a private company, it supports clients from early-stage clinical trials through commercial-scale production, positioning itself as a versatile partner in the rapidly growing CDMO market. Its integrated service model and global footprint enable it to capture demand from biotech and pharmaceutical companies seeking manufacturing outsourcing.

Upcoming Catalysts (preview)

• Q3 2026Major client contract announcement for biologics manufacturing60% success
• TBDExpansion of cell and gene therapy manufacturing capacity70% success
• Q3 2026Pivotal regulatory approval for a client drug manufactured by SK Pharmteco50% success